Position in TKNO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$359,400
+$129,189 QoQ
Shares Held
124,360
+105.3% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TKNO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. TKNO ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in TKNO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $359,400 | 124,360 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $230,211 | 60,582 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $517,564 | 83,613 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $184,717 | 35,591 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $258,724 | 30,985 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $138,409 | 28,597 | Shares | Defined | 2024-11-14 | |
| 2021-06-30 | $283,597 | 11,951 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||